Genetic Diversity and Drug Resistance Profiles in HIV Type 1- and HIV Type 2-Infected Patients from Cape Verde Islands

2012 ◽  
Vol 28 (5) ◽  
pp. 510-522 ◽  
Author(s):  
Vânia Oliveira ◽  
Inês Bártolo ◽  
Pedro Borrego ◽  
Cheila Rocha ◽  
Emília Valadas ◽  
...  
Keyword(s):  
Genetic Diversity ◽  
Drug Resistance ◽  
Cape Verde ◽  
Cape Verde Islands ◽  
Hiv Type 1

scholarly journals Drug Resistance Mutations and Genetic Diversity in Patients Treated for HIV Type 1 Infection in Rural Care Centers in Togo

2016 ◽  
Vol 06 (03) ◽  
pp. 111-115
Author(s):  
Anoumou Dagnra ◽  
Abla Konou ◽  
Mounerou Salou ◽  
Pascal Kodah ◽  
Damobé Kombate ◽  
...  
Keyword(s):  
Genetic Diversity ◽  
Drug Resistance ◽  
Resistance Mutations ◽  
Drug Resistance Mutations ◽  
Hiv Type 1 ◽  
Rural Care

The Neutralization Relationship of HIV Type 1, HIV Type 2, and SIVcpz Is Reflected in the Genetic Diversity that Distinguishes Them

1997 ◽  
Vol 13 (1) ◽  
pp. 7-17 ◽  
Author(s):  
PHILLIPE N. NYAMBI ◽  
BETTY WILLEMS ◽  
WOUTER JANSSENS ◽  
KATRIEN FRANSEN ◽  
JOHN NKENGASONG ◽  
...  
Keyword(s):  
Genetic Diversity ◽  
Hiv Type 1 ◽  
Relationship Of

Drug resistance mutations and genetic diversity in adults treated for HIV type 1 infection in Mauritania

2013 ◽  
Vol 86 (3) ◽  
pp. 404-410 ◽  
Author(s):  
F-Zahra Fall-Malick ◽  
Edmond Tchiakpé ◽  
Sid'Ahmed Ould Soufiane ◽  
Halimatou Diop-Ndiaye ◽  
Abderrahmane Mouhamedoune Baye ◽  
...  
Keyword(s):  
Genetic Diversity ◽  
Drug Resistance ◽  
Resistance Mutations ◽  
Drug Resistance Mutations ◽  
Hiv Type 1

Genetic Diversity and Drug Resistance of HIV Type 1 Circulating Recombinant Form_BC among Drug Users in Guangdong Province

2009 ◽  
Vol 25 (9) ◽  
pp. 869-875 ◽  
Author(s):  
Guolong Yu ◽  
Yan Li ◽  
Jie Li ◽  
Limei Diao ◽  
Xinge Yan ◽  
...  
Keyword(s):  
Genetic Diversity ◽  
Drug Resistance ◽  
Drug Users ◽  
Guangdong Province ◽  
Hiv Type 1

scholarly journals Seroprevalence of Hepatitis C, Hepatitis B, Cytomegalovirus, and Human Immunodeficiency Viruses in Multitransfused Thalassemic Children in Upper Egypt

2016 ◽  
Vol 2016 ◽  
pp. 1-7 ◽  
Author(s):  
Ramadan A. Mahmoud ◽  
Abdel-Azeem M. El-Mazary ◽  
Ashraf Khodeary
Keyword(s):  
Hepatitis C ◽  
Blood Transfusion ◽  
Hepatitis B ◽  
Thalassemia Major ◽  
Upper Egypt ◽  
Egyptian Children ◽  
Hiv Type 1 ◽  
Anti Hiv

Background. Frequent blood transfusions in thalassemia major children expose them to the risk of transfusion-transmitted infections (TTIs). The aim of this study was to estimate the prevalence of hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV), and cytomegalovirus (CMV) in thalassemic children attending the Pediatrics Departments of both Sohag and Minia Universities of Upper Egypt, during the period from May 2014 to May 2015.Methods. Serum samples were screened for hepatitis B surface antigen (HBsAg), anti-HCV, anti-CMV, and anti-HIV type 1 and type 2 using the Vitek Immunodiagnostic Assay System.Results. The frequencies of anti-HCV, HBsAg, anti-CMV, and anti-HIV type 1 and type 2 were found to be 37.11%, 4.12%, 4.12%, 0.00%, and 0.00%, respectively. Seropositivity for anti-HCV, HBsAg, and anti-CMV increased with increasing age of the patients, duration of the disease, serum ferritin level (ng/mL), and liver enzymes (U/L), while it was not significantly associated with gender, frequency of blood transfusion, or the status of splenectomy operation (P>0.05).Conclusion. The frequency of TTIs, especially HCV, is considerably high among Egyptian children with thalassemia major. It is therefore important to implement measures to improve blood transfusion screening, such as polymerase chain reaction, in order to reduce TTIs from blood donor units.

Sign in / Sign up

Export Citation Format

Share Document